{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:57:52Z","timestamp":1790963872254,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272646"],"award-info":[{"award-number":["82272646"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-58525-8","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T21:12:33Z","timestamp":1743801153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A noncanonical role of SAT1 enables anchorage independence and peritoneal metastasis in ovarian cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Cuimiao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuwen","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1848-0748","authenticated-orcid":false,"given":"Tiantian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7615-1638","authenticated-orcid":false,"given":"Siqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8886-0106","authenticated-orcid":false,"given":"Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manman","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5145-5705","authenticated-orcid":false,"given":"Shuzhong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4255-9318","authenticated-orcid":false,"given":"Chaoyun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"58525_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"58525_CR2","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41586-023-06421-w","volume":"620","author":"ZRC Marks","year":"2023","unstructured":"Marks, Z. R. C. et al. Interferon-epsilon is a tumour suppressor and restricts ovarian cancer. Nature 620, 1063\u20131070 (2023).","journal-title":"Nature"},{"key":"58525_CR3","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s43018-023-00599-8","volume":"4","author":"X Zheng","year":"2023","unstructured":"Zheng, X. et al. Single-cell analyses implicate ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancer. Nat. Cancer 4, 1138\u20131156 (2023).","journal-title":"Nat. Cancer"},{"key":"58525_CR4","doi-asserted-by":"crossref","unstructured":"Tavares, V. et al. paradigm shift: a comprehensive review of ovarian cancer management in an era of advancements. Int. J. Mol. Sci. 25, 1845 (2024).","DOI":"10.3390\/ijms25031845"},{"key":"58525_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24845-8","volume":"12","author":"C Pan","year":"2021","unstructured":"Pan, C. et al. Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1. Nat. Commun. 12, 4960 (2021).","journal-title":"Nat. Commun."},{"key":"58525_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42850-x","volume":"14","author":"L Tao","year":"2023","unstructured":"Tao, L. et al. Repression of LSD1 potentiates homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1\/2 and RAD51. Nat. Commun. 14, 7430 (2023).","journal-title":"Nat. Commun."},{"key":"58525_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17127-2","volume":"11","author":"H Kim","year":"2020","unstructured":"Kim, H. et al. Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models. Nat. Commun. 11, 3726 (2020).","journal-title":"Nat. Commun."},{"key":"58525_CR8","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1056\/NEJMoa1910962","volume":"381","author":"A Gonzalez-Martin","year":"2019","unstructured":"Gonzalez-Martin, A. et al. Niraparib in patients with newly diagnosed advanced ovarian cancer. N. Engl. J. Med 381, 2391\u20132402 (2019).","journal-title":"N. Engl. J. Med"},{"key":"58525_CR9","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/s41388-021-02149-x","volume":"41","author":"J Li","year":"2022","unstructured":"Li, J. et al. ROS-regulated phosphorylation of ITPKB by CAMK2G drives cisplatin resistance in ovarian cancer. Oncogene 41, 1114\u20131128 (2022).","journal-title":"Oncogene"},{"key":"58525_CR10","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.cmet.2023.10.002","volume":"35","author":"J Li","year":"2023","unstructured":"Li, J. et al. Tyrosine catabolism enhances genotoxic chemotherapy by suppressing translesion DNA synthesis in epithelial ovarian cancer. Cell Metab. 35, 2044\u20132059 e2048 (2023).","journal-title":"Cell Metab."},{"key":"58525_CR11","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1016\/j.cell.2023.07.004","volume":"186","author":"S Chowdhury","year":"2023","unstructured":"Chowdhury, S. et al. Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer. Cell 186, 3476\u20133498 e3435 (2023).","journal-title":"Cell"},{"key":"58525_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.add7872","volume":"15","author":"N Gupta","year":"2023","unstructured":"Gupta, N. et al. BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor-resistant BRCA-mutant ovarian cancer. Sci. Transl. Med 15, eadd7872 (2023).","journal-title":"Sci. Transl. Med"},{"key":"58525_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ccell.2019.12.015","volume":"37","author":"S Karakashev","year":"2020","unstructured":"Karakashev, S. et al. EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibition. Cancer Cell 37, 157\u2013167 e156 (2020).","journal-title":"Cancer Cell"},{"key":"58525_CR14","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.ccell.2018.05.008","volume":"33","author":"E Gogola","year":"2018","unstructured":"Gogola, E. et al. Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality. Cancer Cell 33, 1078\u20131093 e1012 (2018).","journal-title":"Cancer Cell"},{"key":"58525_CR15","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.ccell.2023.04.017","volume":"41","author":"A Lahtinen","year":"2023","unstructured":"Lahtinen, A. et al. Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma. Cancer Cell 41, 1103\u20131117 e1112 (2023).","journal-title":"Cancer Cell"},{"key":"58525_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41586-018-0597-x","volume":"562","author":"M Song","year":"2018","unstructured":"Song, M. et al. IRE1alpha-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. Nature 562, 423\u2013428 (2018).","journal-title":"Nature"},{"key":"58525_CR17","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1158\/2159-8290.CD-21-1181","volume":"12","author":"CS Chae","year":"2022","unstructured":"Chae, C. S. et al. Tumor-Derived Lysophosphatidic Acid Blunts Protective Type I Interferon Responses in Ovarian Cancer. Cancer Discov. 12, 1904\u20131921 (2022).","journal-title":"Cancer Discov."},{"key":"58525_CR18","doi-asserted-by":"crossref","unstructured":"Quiralte, M. et al. Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer. J. Clin. Invest. 134, e176161 (2024).","DOI":"10.1172\/JCI176161"},{"key":"58525_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41586-023-05758-6","volume":"615","author":"AD Weems","year":"2023","unstructured":"Weems, A. D. et al. Blebs promote cell survival by assembling oncogenic signalling hubs. Nature 615, 517\u2013525 (2023).","journal-title":"Nature"},{"key":"58525_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","volume":"123","author":"CE Ford","year":"2020","unstructured":"Ford, C. E., Werner, B., Hacker, N. F. & Warton, K. The untapped potential of ascites in ovarian cancer research and treatment. Br. J. Cancer 123, 9\u201316 (2020).","journal-title":"Br. J. Cancer"},{"key":"58525_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.molcel.2017.11.025","volume":"69","author":"L Jin","year":"2018","unstructured":"Jin, L. et al. The PLAG1-GDH1 Axis Promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung Cancer. Mol. Cell 69, 87\u201399 e87 (2018).","journal-title":"Mol. Cell"},{"key":"58525_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature17393","volume":"532","author":"L Jiang","year":"2016","unstructured":"Jiang, L. et al. Reductive carboxylation supports redox homeostasis during anchorage-independent growth. Nature 532, 255\u2013258 (2016).","journal-title":"Nature"},{"key":"58525_CR23","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41586-022-04758-2","volume":"605","author":"M Rossi","year":"2022","unstructured":"Rossi, M. et al. PHGDH heterogeneity potentiates cancer cell dissemination and metastasis. Nature 605, 747\u2013753 (2022).","journal-title":"Nature"},{"key":"58525_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-019-1340-y","volume":"571","author":"X Wang","year":"2019","unstructured":"Wang, X. et al. UDP-glucose accelerates SNAI1 mRNA decay and impairs lung cancer metastasis. Nature 571, 127\u2013131 (2019).","journal-title":"Nature"},{"key":"58525_CR25","doi-asserted-by":"crossref","unstructured":"Chap, B. S., Rayroux, N., Grimm, A. J., Ghisoni, E. & Dangaj Laniti, D. Crosstalk of T cells within the ovarian cancer microenvironment. Trends Cancer 10, 1116\u20131130 (2024).","DOI":"10.1016\/j.trecan.2024.09.001"},{"key":"58525_CR26","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ccell.2022.03.008","volume":"40","author":"CM Anadon","year":"2022","unstructured":"Anadon, C. M. et al. Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells. Cancer Cell 40, 545\u2013557 e513 (2022).","journal-title":"Cancer Cell"},{"key":"58525_CR27","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41568-022-00473-2","volume":"22","author":"CE Holbert","year":"2022","unstructured":"Holbert, C. E., Cullen, M. T., Casero, R. A. Jr. & Stewart, T. M. Polyamines in cancer: integrating organismal metabolism and antitumour immunity. Nat. Rev. Cancer 22, 467\u2013480 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"58525_CR28","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger, S., Jiang, Q. & Ganesh, K. Metastasis. Cell 186, 1564\u20131579 (2023).","journal-title":"Cell"},{"key":"58525_CR29","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.cmet.2019.07.014","volume":"30","author":"CF Labuschagne","year":"2019","unstructured":"Labuschagne, C. F., Cheung, E. C., Blagih, J., Domart, M. C. & Vousden, K. H. Cell Clustering Promotes a Metabolic Switch that Supports Metastatic Colonization. Cell Metab. 30, 720\u2013734 e725 (2019).","journal-title":"Cell Metab."},{"key":"58525_CR30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2217332120","volume":"120","author":"AC Boese","year":"2023","unstructured":"Boese, A. C. et al. Succinyl-CoA ligase ADP-forming subunit beta promotes stress granule assembly to regulate redox and drive cancer metastasis. Proc. Natl Acad. Sci. USA 120, e2217332120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58525_CR31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","volume":"23","author":"HK Matthews","year":"2022","unstructured":"Matthews, H. K., Bertoli, C. & de Bruin, R. A. M. Cell cycle control in cancer. Nat. Rev. Mol. Cell Biol. 23, 74\u201388 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"58525_CR32","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.molcel.2022.05.004","volume":"82","author":"S Saxena","year":"2022","unstructured":"Saxena, S. & Zou, L. Hallmarks of DNA replication stress. Mol. Cell 82, 2298\u20132314 (2022).","journal-title":"Mol. Cell"},{"key":"58525_CR33","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41588-021-00842-x","volume":"53","author":"S Sungalee","year":"2021","unstructured":"Sungalee, S. et al. Histone acetylation dynamics modulates chromatin conformation and allele-specific interactions at oncogenic loci. Nat. Genet 53, 650\u2013662 (2021).","journal-title":"Nat. Genet"},{"key":"58525_CR34","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s42003-022-03530-6","volume":"5","author":"I Aye","year":"2022","unstructured":"Aye, I. et al. Placental sex-dependent spermine synthesis regulates trophoblast gene expression through acetyl-coA metabolism and histone acetylation. Commun. Biol. 5, 586 (2022).","journal-title":"Commun. Biol."},{"key":"58525_CR35","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1016\/j.cell.2021.06.007","volume":"184","author":"DJ Puleston","year":"2021","unstructured":"Puleston, D. J. et al. Polyamine metabolism is a central determinant of helper T cell lineage fidelity. Cell 184, 4186\u20134202 e4120 (2021).","journal-title":"Cell"},{"key":"58525_CR36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41580-021-00441-y","volume":"23","author":"M Shvedunova","year":"2022","unstructured":"Shvedunova, M. & Akhtar, A. Modulation of cellular processes by histone and non-histone protein acetylation. Nat. Rev. Mol. Cell Biol. 23, 329\u2013349 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"58525_CR37","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.molcel.2017.06.008","volume":"67","author":"S Sivanand","year":"2017","unstructured":"Sivanand, S. et al. Nuclear Acetyl-CoA Production by ACLY Promotes Homologous Recombination. Mol. Cell 67, 252\u2013265 e256 (2017).","journal-title":"Mol. Cell"},{"key":"58525_CR38","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/0006-2952(92)90424-H","volume":"44","author":"PR Libby","year":"1992","unstructured":"Libby, P. R. & Porter, C. W. Inhibition of enzymes of polyamine back-conversion by pentamidine and berenil. Biochem Pharm. 44, 830\u2013832 (1992).","journal-title":"Biochem Pharm."},{"key":"58525_CR39","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","volume":"7","author":"DS Tan","year":"2006","unstructured":"Tan, D. S., Agarwal, R. & Kaye, S. B. Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol. 7, 925\u2013934 (2006).","journal-title":"Lancet Oncol."},{"key":"58525_CR40","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.ccell.2024.08.016","volume":"42","author":"E Bayraktar","year":"2024","unstructured":"Bayraktar, E., Chen, S., Corvigno, S., Liu, J. & Sood, A. K. Ovarian cancer metastasis: Looking beyond the surface. Cancer Cell 42, 1631\u20131636 (2024).","journal-title":"Cancer Cell"},{"key":"58525_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s43018-020-00160-x","volume":"2","author":"S Wu","year":"2021","unstructured":"Wu, S. et al. Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma. Nat. Cancer 2, 189\u2013200 (2021).","journal-title":"Nat. Cancer"},{"key":"58525_CR42","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ccell.2023.03.002","volume":"41","author":"W Zhou","year":"2023","unstructured":"Zhou, W. et al. Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis. Cancer Cell 41, 740\u2013756 e710 (2023).","journal-title":"Cancer Cell"},{"key":"58525_CR43","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41556-024-01372-4","volume":"26","author":"D Murthy","year":"2024","unstructured":"Murthy, D. et al. Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Nat. Cell Biol. 26, 613\u2013627 (2024).","journal-title":"Nat. Cell Biol."},{"key":"58525_CR44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2315509121","volume":"121","author":"D Murthy","year":"2024","unstructured":"Murthy, D. et al. The MUC1-HIF-1alpha signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling. Proc. Natl Acad. Sci. USA 121, e2315509121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58525_CR45","doi-asserted-by":"crossref","unstructured":"Li, J. et al. ODF2L acts as a synthetic lethal partner with WEE1 inhibition in epithelial ovarian cancer models. J Clin. Invest. 133, e161544 (2023).","DOI":"10.1172\/JCI161544"},{"key":"58525_CR46","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41586-022-04638-9","volume":"604","author":"D Gallo","year":"2022","unstructured":"Gallo, D. et al. CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition. Nature 604, 749\u2013756 (2022).","journal-title":"Nature"},{"key":"58525_CR47","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1016\/j.cell.2023.09.011","volume":"186","author":"D Mossmann","year":"2023","unstructured":"Mossmann, D. et al. Arginine reprograms metabolism in liver cancer via RBM39. Cell 186, 5068\u20135083 e5023 (2023).","journal-title":"Cell"},{"key":"58525_CR48","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41586-023-05891-2","volume":"616","author":"MS Lee","year":"2023","unstructured":"Lee, M. S. et al. Ornithine aminotransferase supports polyamine synthesis in pancreatic cancer. Nature 616, 339\u2013347 (2023).","journal-title":"Nature"},{"key":"58525_CR49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2319429121","volume":"121","author":"X Han","year":"2024","unstructured":"Han, X. et al. Activation of polyamine catabolism promotes glutamine metabolism and creates a targetable vulnerability in lung cancer. Proc. Natl Acad. Sci. USA 121, e2319429121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58525_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.apsb.2023.09.014","volume":"14","author":"W Ye","year":"2024","unstructured":"Ye, W. et al. Anti-atherosclerotic effects and molecular targets of ginkgolide B from Ginkgo biloba. Acta Pharm. Sin. B 14, 1\u201319 (2024).","journal-title":"Acta Pharm. Sin. B"},{"key":"58525_CR51","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.cell.2024.02.009","volume":"187","author":"C Swanton","year":"2024","unstructured":"Swanton, C. et al. Embracing cancer complexity: Hallmarks of systemic disease. Cell 187, 1589\u20131616 (2024).","journal-title":"Cell"},{"key":"58525_CR52","doi-asserted-by":"publisher","first-page":"e2354352","DOI":"10.1001\/jamanetworkopen.2023.54352","volume":"7","author":"J Bjorklund","year":"2024","unstructured":"Bjorklund, J. et al. Risk of Venous Thromboembolic Events After Surgery for Cancer. JAMA Netw. Open 7, e2354352 (2024).","journal-title":"JAMA Netw. Open"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58525-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58525-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58525-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:41:49Z","timestamp":1743828109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58525-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58525"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-58525-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"19 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3174"}}